The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer-Reference-Cited by-同舟云学术

The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer

Published:2017-12-19 Issue:5 Volume:78 Page:1225-1240
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Ekambaram Prasanna,Lee Jia-Ying (Lloyd),Hubel Nathaniel E.,Hu Dong,Yerneni Saigopalakrishna,Campbell Phil G.,Pollock Netanya,Klei Linda R.,Concel Vincent J.,Delekta Phillip C.,Chinnaiyan Arul M.,Tomlins Scott A.,Rhodes Daniel R.,Priedigkeit Nolan,Lee Adrian V.,Oesterreich Steffi,McAllister-Lucas Linda M.,Lucas Peter C.

Funder

HHS | NIH | National Cancer Institute (NCI)

University of Pittsburgh Cancer Institute (UPCI)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valsartan as a prophylactic treatment against breast cancer development and niche activation: What molecular sequels follow chronic AT-1R blockade?;Life Sciences;2024-09

2. Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death;Blood Advances;2024-07-29

3. Insights into mechanisms of MALT1 allostery from NMR and AlphaFold dynamic analyses;Communications Biology;2024-07-16

4. Modulation of ACE2/Ang1-7/Mas and ACE/AngII/AT1 axes affects anticancer properties of sertraline in MCF-7 breast cancer cells;Biochemistry and Biophysics Reports;2024-07

5. The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway;Cell Biology and Toxicology;2024-06-12